Mohsen Ayati

743 total citations
66 papers, 515 citations indexed

About

Mohsen Ayati is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Mohsen Ayati has authored 66 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Mohsen Ayati's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Mohsen Ayati is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Bladder and Urothelial Cancer Treatments (11 papers). Mohsen Ayati collaborates with scholars based in Iran, United States and Australia. Mohsen Ayati's co-authors include Mohammad Reza Nowroozi, Erfan Amini, Laleh Sharifi, Monireh Mohsenzadegan, Masoumeh Kourosh‐Arami, Sayed-Mohammad Hasheminasab, Mohammad Hossein Modarressi, Alireza Abdollahi, Farhad Pishgar and Farshad Farzadfar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Urology and British Journal of Urology.

In The Last Decade

Mohsen Ayati

60 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohsen Ayati Iran 13 179 173 155 74 66 66 515
Richard Slade United Kingdom 14 149 0.8× 188 1.1× 70 0.5× 73 1.0× 102 1.5× 38 641
Andrea Bosio Italy 11 89 0.5× 105 0.6× 185 1.2× 24 0.3× 29 0.4× 45 393
Vito Mancini Italy 18 173 1.0× 240 1.4× 294 1.9× 77 1.0× 140 2.1× 64 805
R. J. SHEARER United Kingdom 14 86 0.5× 95 0.5× 369 2.4× 40 0.5× 104 1.6× 25 621
Laura Izquierdo Spain 17 196 1.1× 419 2.4× 354 2.3× 150 2.0× 81 1.2× 72 832
Pridvi Kandagatla United States 9 109 0.6× 87 0.5× 105 0.7× 50 0.7× 178 2.7× 29 423
Dean Ruether Canada 12 106 0.6× 213 1.2× 242 1.6× 93 1.3× 263 4.0× 39 710
Sze Chai Chan Hong Kong 12 106 0.6× 79 0.5× 102 0.7× 39 0.5× 131 2.0× 31 502
Po‐Ming Chow Taiwan 14 164 0.9× 74 0.4× 154 1.0× 40 0.5× 58 0.9× 48 501
J Dvořáček Czechia 13 84 0.5× 350 2.0× 148 1.0× 32 0.4× 60 0.9× 56 609

Countries citing papers authored by Mohsen Ayati

Since Specialization
Citations

This map shows the geographic impact of Mohsen Ayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Ayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Ayati more than expected).

Fields of papers citing papers by Mohsen Ayati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Ayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Ayati. The network helps show where Mohsen Ayati may publish in the future.

Co-authorship network of co-authors of Mohsen Ayati

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Ayati. A scholar is included among the top collaborators of Mohsen Ayati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Ayati. Mohsen Ayati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowroozi, Mohammad Reza, Erfan Amini, Ali Nowroozi, et al.. (2023). National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period. International Journal of Cancer Management. 16(1). 2 indexed citations
2.
Ayati, Mohsen, et al.. (2023). A rare case report of muscular metastasis of prostate cancer. Urology Case Reports. 51. 102619–102619. 1 indexed citations
3.
4.
5.
Ayati, Mohsen, et al.. (2020). Serum and Urine Levels of Vascular Endothelial Growth Factor as Prognostic Markers in Patients with Bladder Cancer. SHILAP Revista de lepidopterología. 11(2). 198–202. 1 indexed citations
6.
Ayati, Mohsen, et al.. (2020). Management of primary Ewing sarcoma of the kidney with inferior vena cava (IVC) tumor thrombosis. Urology Case Reports. 34. 101510–101510.
7.
Ayati, Mohsen, Gholamreza Pourmand, Peiman Haddad, et al.. (2019). Economic Burden of Prostate Cancer in Iran: Measuring Costs and Quality of Life. SHILAP Revista de lepidopterología. 7 indexed citations
8.
Ayati, Mohsen, et al.. (2019). Radical cystectomy for management of inflammatory myofibroblastic tumor of the urinary bladder: A rare case report. Urology Case Reports. 27. 100997–100997. 3 indexed citations
9.
Ayati, Mohsen, et al.. (2018). A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer. Pathology - Research and Practice. 214(12). 2018–2024. 4 indexed citations
10.
Ayati, Mohsen, et al.. (2017). Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer. Urology Case Reports. 13. 158–159. 5 indexed citations
11.
Afsharpad, Mandana, Mohammad Reza Nowroozi, Maryam Beigom Mobasheri, et al.. (2017). Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder. Pathology & Oncology Research. 25(1). 191–199. 18 indexed citations
12.
Nowroozi, Mohammad Reza, et al.. (2016). Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer. Nephro-Urology Monthly. 8(6). e39984–e39984. 8 indexed citations
13.
Ayati, Mohsen, et al.. (2016). PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data. Kidney Research and Clinical Practice. 35(2). 96–101. 2 indexed citations
14.
Pourmand, Gholamreza, et al.. (2015). Age-specific reference ranges of serum prostate-specific antigen in Iranian men. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Ayati, Mohsen, et al.. (2015). Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences. Nephro-Urology Monthly. 7(5). e27343–e27343. 7 indexed citations
16.
Ayati, Mohsen, et al.. (2015). Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men. Nephro-Urology Monthly. 7(2). e26752–e26752. 3 indexed citations
17.
Nowroozi, Mohammad Reza, et al.. (2014). Assessment of testicular perfusion prior to sperm extraction predicts success rate and decreases the number of required biopsies in patients with non-obstructive azoospermia. International Urology and Nephrology. 47(1). 53–58. 13 indexed citations
18.
Hasheminasab, Sayed-Mohammad, et al.. (2010). Are GSTM1, GSTT1 and CAG Repeat Length of Androgen Receptor Gene Polymorphisms Associated with Risk of Prostate Cancer in Iranian Patients?. Pathology & Oncology Research. 17(2). 269–275. 24 indexed citations
19.
Margreiter, Markus, Elisabeth Eckersberger, Julia B. Finkelstein, et al.. (2009). Gene polymorphisms and prostate cancer: the evidence. British Journal of Urology. 104(11). 1560–1572. 26 indexed citations
20.
Ayati, Mohsen, et al.. (2008). Association of TGIFLX/Y mRNA expression with prostate cancer. Medical Oncology. 26(1). 73–77. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Slade Breakdown of academic impact, for papers by Andrea Bosio Breakdown of academic impact, for papers by Vito Mancini Breakdown of academic impact, for papers by R. J. SHEARER Breakdown of academic impact, for papers by Laura Izquierdo Breakdown of academic impact, for papers by Pridvi Kandagatla Breakdown of academic impact, for papers by Dean Ruether Breakdown of academic impact, for papers by Sze Chai Chan Breakdown of academic impact, for papers by Po‐Ming Chow Breakdown of academic impact, for papers by J Dvořáček
Rankless by CCL
2026